Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-20-004955
Filing Date
2020-05-14
Accepted
2020-05-14 16:47:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 43483
  Complete submission text file 0000950123-20-004955.txt   44373
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)